201 Bone safety data in adolescents with moderate-to-severe atopic dermatitis treated with abrocitinib: interim results from the JADE EXTEND MRI substudy von Zdybski, J., Wollenberg, A., Flohr, C., Brunner, P.M., Högler, W., Egeberg, A., Irvine, A.D., Fan, H., Biswas, P., Radi, Z., Farooqui, S.A., Koppensteiner, H., Sherlock, S.P., Chan, G.

Volltext

Efficacy and safety of dupilumab treatment with concomitant topical corticosteroids in children aged 6 months to 5 years with severe atopic dermatitis von Paller, A.S., Pinter, A., Lee, L. Wine, Aschoff, R., Zdybski, J., Schnopp, C., Rossi, A.B., Praestgaard, A., Bansal, A., Shumel, B., Prescilla, R., Bastian, M.

Volltext

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial von Paller, Amy S, Simpson, Eric L, Siegfried, Elaine C, Cork, Michael J, Wollenberg, Andreas, Arkwright, Peter D, Soong, Weily, Gonzalez, Mercedes E, Schneider, Lynda C, Sidbury, Robert, Lockshin, Benjamin, Meltzer, Steven, Wang, Zhixiao, Mannent, Leda P, Amin, Nikhil, Sun, Yiping, Laws, Elizabeth, Akinlade, Bolanle, Dillon, Myles, Kosloski, Matthew P, Kamal, Mohamed A, Dubost-Brama, Ariane, Patel, Naimish, Weinreich, David M, Yancopoulos, George D, O’Malley, John T, Bansal, Ashish, Pepper, Amber, Cohen, David, Pariser, David, Leflein, Jeffrey, Weinberg, Jeffrey, Browning, John, Teng, Joyce, Wine Lee, Lara, Sher, Lawrence, Diaz, Lucia, Schneider, Lynda, Rupp, Ned, Ong, Peck, Cartwright, Robert, Pinter, Andreas, Schnopp, Christina, Korkosz, Anna, Bystrzanowska, Dorota, Sygula, Ewa, Zdybski, Jacek, Padlewska, Kamila

Volltext

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo von Rosmarin, David, Passeron, Thierry, Pandya, Amit G., Grimes, Pearl, Harris, John E., Desai, Seemal R., Lebwohl, Mark, Ruer-Mulard, Mireille, Seneschal, Julien, Wolkerstorfer, Albert, Kornacki, Deanna, Sun, Kang, Butler, Kathleen, Ezzedine, Khaled

Volltext

519 - Efficacy of prolonged ruxolitinib cream treatment for vitiligo among patients with limited or no initial response at 6 months von Wolkerstorfer, Albert, Gooderham, Melinda J, Sebastian, Michael, Rosmarin, David, Blauvelt, Andrew, Alam, Maryam Shayesteh, Zdybski, Jacek, Wei, Shaoceng, Kornacki, Deanna, Passeron, Thierry, Harris, John E

Volltext